Skip to content
10-K

Annual Report

Medtronic plc MDT

0001613103-25-000091

← back to feed
Filed
Jun 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jun 17, 2025 1.28B sh
Short Term Debt FY 2025 · Apr 26, 2024 $1.09B
Short Term Investments FY 2025 · Apr 26, 2024 $6.72B
Cash And Equivalents FY 2025 · Apr 26, 2024 $1.28B
Stockholders Equity FY 2025 · Apr 26, 2024 $50.21B
Current Liabilities FY 2025 · Apr 26, 2024 $10.79B
Total Liabilities FY 2025 · Apr 26, 2024 $39.56B
Current Assets FY 2025 · Apr 26, 2024 $21.94B
Total Assets FY 2025 · Apr 26, 2024 $89.98B
Shares Diluted FY 2025 · Apr 28, 2023 1.33B sh
Stock Repurchased FY 2025 · Apr 28, 2023 $645M
Dividends Paid FY 2025 · Apr 28, 2023 $3.62B
Capex FY 2025 · Apr 28, 2023 $1.46B
Operating Cash Flow FY 2025 · Apr 28, 2023 $6.04B
Eps Diluted FY 2025 · Apr 28, 2023 $2.82
Eps Basic FY 2025 · Apr 28, 2023 $2.83
Sga Expense FY 2025 · Apr 28, 2023 $10.42B
Net Income FY 2025 · Apr 28, 2023 $3.76B
Operating Income FY 2025 · Apr 28, 2023 $5.49B
Cost Of Revenue FY 2025 · Apr 28, 2023 $10.72B
Revenue FY 2025 · Apr 28, 2023 $31.23B